Blended Treatment för PTSD: A New Format of Computer-Assisted Trauma-Focused Cognitive Behavioral Therapy
Key facts
- Who runs it
- Karolinska Institutet
- Where
- Sweden1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 160 people, planned
- Started
- 10 Mar 2023
- Expected to end
- 10 Oct 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Blended Trauma focused Cognitive Behavioral Therapy (B-Tf-CBT)
- Prolonged exposure
- Record updated
- 26 December 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- PTSD according to Diagnostic and Statistical Manual of mental disorders 5 as primary problem
- ≥ 18 years
- Basic knowledge of speaking and writing Swedish
- No other psychological treatment at the same time
- No ongoing threats or violence
- If antidepressant medication, stable dose 6 weeks before starting treatment
- Have access to the internet and a computer
- Willingness/ability to participate after receiving information about what participation entails
Who cannot take part
- Other diagnosis or problem is assessed as primary to PTSD
- Moderate to severe suicidal risk
- PTSD from childhood trauma that the person cannot remember
This trial is currently available in Sweden.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
A Randomized Controlled Non-inferiority Trial testing if the new experimental Blended Trauma focused cognitive behavioral therapy (B-TF-CBT) for post traumatic stress disorder (PTSD), is non-inferior to gold standard control treatment Prolonged Exposure (PE).
Read full original descriptionShow less
Research question and hypothesis
Primary
1. Is bTF-CT non-inferior to prolonged exposure (PE) when delivered in routine clinical care in terms of PTSD symptoms on the PCL-5 post-treatment?
Secondary: 2. Is bTF-CT non-inferior to prolonged exposure (PE) when delivered in routine clinical care in terms of PTSD symptoms on the PCL-5 at 6 and 12 months follow up? 3. Are there significant differences between bTF-CT and PE when delivered in routine clinical care in terms of depression, anxiety, insomnia, functionality, complex PTSD, other PTSD-measures and treatment satisfaction post-treatment and at 6 and 12 months follow up?
The study will be conducted at 3-6 outpatient clinics in Region Stockholm, Sweden.
The 2 groups in the trial
- Blended Trauma focused Cognitive Behavioral Therapy (B-Tf-CBT)Treatment being tested
B-Tf-CBT shares key features with Internet-based CBT (I-CBT) in that it is based on a digital support accessible to the patient. This digital support equips blended treatment with the same proposed advantages as I-CBT in terms of improving treatment accessibility, adherence, and reducing therapist-time. In addition, incorporating 6 biweekly face-to-face sessions to facilitate and augment delivery of more demanding components of TF-CBT such as memory exposure.
- Prolonged exposureExisting treatment, for comparison
Gold standard Tf-CBT Prolonged exposure will constitute the control condition. Prolonged exposure will be delivered by trained therapists under supervision adhering to the evidence based manual delivered face-to-face over 9-15 weeks.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Evaluation of Blended CBT for PTSD in Regular Care: A New Format of Computer-Assisted Trauma-Focused Cognitive Behavioral Therapy: A Randomized Controlled Non-inferiority Trial
- Record updated
- 26 December 2025